Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
暂无分享,去创建一个
J. Baddley | G. Rahav | V. Morrison | D. Kontoyiannis | O. Lortholary | S. Shoham | K. Marr | E. Bow | R. Herbrecht | T. Patterson | A. Schmitt-Hoffmann | J. Maertens | I. Raad | O. Cornely | W. Hope | A. Ullmann | M. Karthaus | D. Selleslag | M. Giladi | W. Heinz | Dong‐Gun Lee | I. Oren | B. Zeiher | M. Aoun | George R. Thompson | D. Neofytos | Rochelle M Maher | Misun Lee | G. Thompson | Rochelle M. Maher